Paradigm Biocapital Advisors LP - Sep 30, 2025 SCHEDULE 13G/A Report for Agios Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (AGIO)

Filing Manager: Paradigm Biocapital Advisors LP
Reporting Manager: Paradigm BioCapital Advisors LP
Security: Agios Pharmaceuticals, Inc. Common Stock, $0.001 par value per share
Symbol: AGIO
Shares outstanding: 58.6M shares
Disclosed Ownership: 2.87M shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Date filed: 11/14/2025, 04:34 PM
Date of event: Sep 30, 2025
Previous filing: Aug 28, 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Paradigm BioCapital Advisors LP	4.9%	2.87M	2.87M	/s/ David K. Kim	David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC	4.9%	2.87M	2.87M	/s/ David K. Kim	David K. Kim / Authorized Signatory
Senai Asefaw, M.D.	4.9%	2.87M	2.87M	/s/ Senai Asefaw, M.D.	N/A
Paradigm BioCapital International Fund Ltd.	4.4%	2.54M	2.54M	/s/ David K. Kim	David K. Kim / Authorized Signatory